OverviewSuggest Edit

The mission of every team member at Carmat is to contribute to the development of innovative artificial organs – the artificial heart today, tomorrow other vital organs – to treat millions of patients affected by advanced disease of these organs and to restore their normal life.

By sharing our expertise and through our daily actions, we seek to achieve results that will benefit first and foremost patients and physicians, but also healthcare systems, subcontractors, employees and shareholders.

TypePublic
Founded2008
HQVélizy-Villacoublay, FR
Websitecarmatsa.com

Latest Updates

Employees (est.) (Sept 2020)103
Job Openings2
Share Price (Sept 2020)€19.5
Cybersecurity ratingAMore

Carmat Office Locations

Carmat has an office in Vélizy-Villacoublay
Vélizy-Villacoublay, FR (HQ)
36 Avenue de l'Europe immeuble l
Show all (1)

Carmat Financials and Metrics

Carmat Revenue

Market capitalization (22-Sept-2020)

247.8m

Closing stock price (22-Sept-2020)

19.5
Carmat's current market capitalization is €247.8 m.
Show all financial metrics

Carmat Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Carmat Online and Social Media Presence

Embed Graph

Carmat Blogs

Annual Shareholders’ Meeting of March 30, 2020: online login details

L’article Annual Shareholders’ Meeting of March 30, 2020: online login details est apparu en premier sur Carmat.

Annual Shareholders’ Meeting of March 30, 2020: procedures for participating and voting within the context of the coronavirus epidemic

L’article Annual Shareholders’ Meeting of March 30, 2020: procedures for participating and voting within the context of the coronavirus epidemic est apparu en premier sur Carmat.

CARMAT announces that it has achieved record individual support of 2 years with its bioprosthesis

L’article CARMAT announces that it has achieved record individual support of 2 years with its bioprosthesis est apparu en premier sur Carmat.

CARMAT confirms the submission of a “Forfait Innovation” dossier in France and its eligibility with observations received from the French National Authority for Health (HAS)

L’article CARMAT confirms the submission of a “Forfait Innovation” dossier in France and its eligibility with observations received from the French National Authority for Health (HAS) est apparu en premier sur Carmat.

CARMAT reports its 2019 annual results and confirms its 2020 objectives

L’article CARMAT reports its 2019 annual results and confirms its 2020 objectives est apparu en premier sur Carmat.

CARMAT announces FDA full approval to initiate US clinical feasibility study of its total artificial heart

L’article CARMAT announces FDA full approval to initiate US clinical feasibility study of its total artificial heart est apparu en premier sur Carmat.
Show more

Carmat Frequently Asked Questions

  • When was Carmat founded?

    Carmat was founded in 2008.

  • How many employees does Carmat have?

    Carmat has 103 employees.

  • Who are Carmat competitors?

    Competitors of Carmat include Electromed, Sientra and EDAP TMS.

  • Where is Carmat headquarters?

    Carmat headquarters is located at 36 Avenue de l'Europe immeuble l, Vélizy-Villacoublay.

  • Where are Carmat offices?

    Carmat has an office in Vélizy-Villacoublay.

  • How many offices does Carmat have?

    Carmat has 1 office.